Attributes | Values |
---|
rdf:type
| |
Description
| - Using a highly selective neuronal NO synthase (nNOS) inhibitor, Nw-propyl-L-arginine (L-NPA), we investigated the effects of nNOS in the development of seizures and neurobiological changes, during status epilepticus (SE) and the early latent period, using a kainic acid (KA)-induced seizure model in C57BL/6J mice. The results suggest that nNOS plays a contributory role in seizure severity during SE and is important for neurobiological changes, associated with the development of chronic epilepsy, in the early latent period of epileptogenesis and may represent a novel target for pharmacological modulation in the treatment of epilepsy
- Using a highly selective neuronal NO synthase (nNOS) inhibitor, Nw-propyl-L-arginine (L-NPA), we investigated the effects of nNOS in the development of seizures and neurobiological changes, during status epilepticus (SE) and the early latent period, using a kainic acid (KA)-induced seizure model in C57BL/6J mice. The results suggest that nNOS plays a contributory role in seizure severity during SE and is important for neurobiological changes, associated with the development of chronic epilepsy, in the early latent period of epileptogenesis and may represent a novel target for pharmacological modulation in the treatment of epilepsy (en)
|
Title
| - N-w-Propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses
- N-w-Propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses (en)
|
skos:prefLabel
| - N-w-Propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses
- N-w-Propyl-L-arginine (L-NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses (en)
|
skos:notation
| - RIV/67985823:_____/12:00385447!RIV13-GA0-67985823
|
http://linked.open...avai/predkladatel
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - I, P(GAP303/10/0999), Z(AV0Z50110509)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/67985823:_____/12:00385447
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - aberrant sprouting; gliosis; nitric oxide; seizure; telemetry (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Neuroscience
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Otáhal, Jakub
- Beamer, E.
- Sills, G. J.
- Thippeswamy, T.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1111/j.1460-9568.2012.08234.x
|
is http://linked.open...avai/riv/vysledek
of | |